Drug
Insulin Susp Isophane Recombinant Human
Insulin Susp Isophane Recombinant Human: highest development phase Approved, developed by Novo Nordisk. 1 trial record tracked on RxWires.
- Highest phase
- Approved
- Developer
- Novo Nordisk
Trials
| Drug | Phase | Indication |
|---|---|---|
| NOVOLIN N | Approved |
Latest
No recent events.
Follow Insulin Susp Isophane Recombinant Human on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.